These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Significance of detecting E-selectin of serum and pleural effusion in differentiating benign and malignant diseases].
    Author: Liu G, Li C, Zhong X.
    Journal: Zhonghua Jie He He Hu Xi Za Zhi; 1998 Sep; 21(9):556-8. PubMed ID: 11360510.
    Abstract:
    OBJECTIVE: To evaluate the significance of detecting E-selectin of serum and pleural effusion in differentiating benign and malignant diseases. METHOD: E-selectin of serum and pleural effusion in 23 patients with tuberculous pleurisy and 21 patients with lung cancer involving pleura was detected by ELISA method. RESULT: E-selectin of serum(44 +/- 5 micrograms/L) and pleural effusion (24 +/- 3 micrograms/L) in patients with tuberculous pleurisy was much higher than that of serum (27 +/- 4 micrograms/L) and pleural effusion (11 +/- 3 micrograms/L) in lung cancer patients (P < 0.01). In addition, E-selection of serum in patients with tuberculous pleurisy was also much higher than that of pleural effusion (P < 0.01). And there was no correlation between E-selectin of serum and that of pleural effusion in patients with tuberculous pleurisy (r = 0.16, P > 0.05). CONCLUSION: E-selectin of serum and pleural effusion in patients with tuberculous pleurisy is produced from different sources. And E-selectin in patients with tuberculous pleurisy is much higher than those with lung cancer. Thence detecting E-selectin of serum and pleural effusion might be helpful for differentiating benign and malignant diseases.
    [Abstract] [Full Text] [Related] [New Search]